Amy Parison
Förmögenhet: 36 950 $ per 2026-10-31
Förmögenhet: 36 950 $ per 2026-10-31
Amy Parison is currently Chief Financial Officer & Senior Vice President at Editas Medicine, Inc. since 2025.
Formerly, Ms. Parison was Corporate Controller at Rubius Therapeutics, Inc. from 2021 to 2022.
Education includes undergraduate and graduate degrees from Babson College.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
EDITAS MEDICINE, INC. 0,01 % | 2026-09-03 | 13 839 ( 0,01 % ) | 36 950 $ | 2026-10-31 |
| Företag | Position | Start |
|---|---|---|
| EDITAS MEDICINE, INC. | Finansdirektör/CFO | 2025-03-28 |
| Företag | Position | Slut |
|---|---|---|
| RUBIUS THERAPEUTICS | Verksamhetschef | 2021-08-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
Babson College
Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Editas Medicine, Inc.
Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Rubius Therapeutics, Inc.
Rubius Therapeutics, Inc. BiotechnologyHealth Technology Develops red cell therapeutics for cancer treatment | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån